Elevated Blood Phosphorylated Tau 181 Levels Predict Cognitive and Functional Decline in Alzheimer’s Disease and Mild Cognitive Impairment

Evaluations of the Performance of the Aß42/Aß40 Ratios, p-Tau181 and p-Tau217 Assays in Alzheimer’s Disease Plasma

Binding Characteristics of PRX012 Surrogate Demonstrate Potent Engagement of Toxic Amyloid Beta Protofibrils and Robust Clearance of Pyroglutamate-modified Amyloid Beta

Markers of Vitamin B1 Status in Relation to Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease and Cognitive Performance